Johnson & Johnson
JNJ
#24
Rank
A$768.59 B
Marketcap
A$319.29
Share price
0.16%
Change (1 day)
41.98%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

Revenue for Johnson & Johnson (JNJ)

Revenue in 2026 (TTM): A$143.83 Billion

According to Johnson & Johnson's latest financial reports the company's current revenue (TTM ) is A$133.30 Billion. In 2025 the company made a revenue of A$140.62 Billion a decrease over the revenue in the year 2024 that were of A$142.79 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Johnson & Johnson from 1996 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) A$143.83 B2.28%
2025 A$140.62 B-1.52%
2024 A$142.79 B14.24%
2023 A$124.99 B-6.68%
2022 A$133.94 B3.55%
2021 A$129.34 B20.43%
2020 A$107.40 B-8.36%
2019 A$117.20 B1.21%
2018 A$115.80 B18.26%
2017 A$97.92 B-1.81%
2016 A$99.73 B3.68%
2015 A$96.19 B5.91%
2014 A$90.82 B13.61%
2013 A$79.94 B23.59%
2012 A$64.68 B2%
2011 A$63.42 B4.6%
2010 A$60.63 B-12.01%
2009 A$68.90 B-23.74%
2008 A$90.35 B29.3%
2007 A$69.88 B3.31%
2006 A$67.64 B-2.02%
2005 A$69.03 B12.83%
2004 A$61.18 B8.64%
2003 A$56.31 B-12.58%
2002 A$64.42 B1.19%
2001 A$63.67 B20.53%
2000 A$52.82 B24.76%
1999 A$42.34 B9.59%
1998 A$38.63 B11.24%
1997 A$34.73 B27.62%
1996 A$27.21 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novartis
NVS
A$78.27 B-41.29%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$87.58 B-34.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$62.43 B-53.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
A$49.08 B-63.18%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
A$99.94 B-25.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$76.72 B-42.44%๐Ÿ‡ซ๐Ÿ‡ท France
Gilead Sciences
GILD
A$40.72 B-69.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
A$34.74 B-73.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$90.98 B-31.75%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$61.09 B-54.17%๐Ÿ‡ฌ๐Ÿ‡ง UK